Amir Kalali, MD

Amir Kalali, MD
Vice President, Medical and Scientific Services
CNS Global Therapeutic Team Leader, Quintiles

Amir Kalali, MD, is Vice President, Medical and Scientific Services, and CNS Global Therapeutic Team Leader for Quintiles. He is an expert in CNS clinical trial methodology, and is globally responsible for the medical and scientific aspects of development programs in psychiatry and neurology. Dr. Kalali is also Professor of Psychiatry at the University of California, San Diego. As the Founding Chairman and current Executive Secretary of the Executive Committee of the International Society for CNS Drug Development, and as a member of the Scientific Committee of the International Society for CNS Clinical Trials and Methodology, Dr. Kalali actively facilitates scientific collaboration between academia, government, and pharmaceutical industry scientists. Dr. Kalali is the Editor of the journal Psychiatry and has published numerous peer-reviewed papers.

White Paper


Challenges in Conducting Trials in Alzheimer's Disease

This paper examines the opportunities for conducting clinical trials in Alzheimer's disease in low and middle income countries.

Read more